by healthadvances Posted on September 18, 2020 How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen Read More
by healthadvances Posted on July 30, 2020January 13, 2021 Value Creation in Molecular Diagnostics: A Game of Luck or Skill? Read More
by healthadvances Posted on July 16, 2020July 16, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends) Read More
by healthadvances Posted on May 8, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition) Read More
by healthadvances Posted on May 8, 2020 Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition) Read More
by healthadvances Posted on April 28, 2020April 28, 2020 How SARS-CoV-2 Will Catalyze Decentralized Testing Read More
by healthadvances Posted on April 24, 2020 The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed? Read More
by healthadvances Posted on April 16, 2020April 16, 2020 US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany? Read More
by healthadvances Posted on August 1, 2019April 13, 2020 Health Advances Hosts 11th Annual Cocktail Reception at AACC – “The Clinical Lab of the Future” Read More
by healthadvances Posted on June 11, 2019April 13, 2020 What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting Read More
by healthadvances Posted on June 7, 2019April 13, 2020 Highlights from Health Advances Executive Panel – Precision Medicine: Oncology and Beyond Read More
by healthadvances Posted on February 27, 2019November 13, 2020 Danaher’s Massive Biopharma Acquisition: It’s the Fit that Counts Read More
by healthadvances Posted on July 24, 2018April 13, 2020 Join Health Advances at AACC for Our 10th Annual Cocktail Reception Read More
by healthadvances Posted on July 10, 2018April 13, 2020 OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology Read More
by healthadvances Posted on July 9, 2018April 13, 2020 Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles Read More
by healthadvances Posted on June 15, 2018April 13, 2020 Commercial and Developmental Innovation: What Can We Learn from Gene Therapies? Read More
by healthadvances Posted on March 22, 2018April 15, 2020 Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress Read More